Carolina Wealth Advisors LLC Buys 5,582 Shares of Cardinal Health, Inc. (NYSE:CAH)

Carolina Wealth Advisors LLC grew its holdings in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 291.2% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,499 shares of the company's stock after purchasing an additional 5,582 shares during the period. Cardinal Health makes up 0.6% of Carolina Wealth Advisors LLC's portfolio, making the stock its 27th biggest position. Carolina Wealth Advisors LLC's holdings in Cardinal Health were worth $1,033,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of the business. Geode Capital Management LLC raised its holdings in shares of Cardinal Health by 1.9% during the fourth quarter. Geode Capital Management LLC now owns 5,859,132 shares of the company's stock worth $691,145,000 after acquiring an additional 109,273 shares in the last quarter. Invesco Ltd. raised its holdings in shares of Cardinal Health by 4.6% during the fourth quarter. Invesco Ltd. now owns 3,182,514 shares of the company's stock worth $376,396,000 after acquiring an additional 140,368 shares in the last quarter. Marshall Wace LLP raised its holdings in shares of Cardinal Health by 154.6% during the fourth quarter. Marshall Wace LLP now owns 3,151,736 shares of the company's stock worth $372,756,000 after acquiring an additional 1,913,892 shares in the last quarter. Northern Trust Corp raised its holdings in shares of Cardinal Health by 16.2% during the fourth quarter. Northern Trust Corp now owns 3,037,849 shares of the company's stock worth $359,286,000 after acquiring an additional 422,755 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of Cardinal Health by 4.3% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,321,797 shares of the company's stock worth $274,599,000 after acquiring an additional 94,768 shares in the last quarter. Hedge funds and other institutional investors own 87.17% of the company's stock.

Cardinal Health Trading Up 1.0%

CAH traded up $1.57 during midday trading on Friday, reaching $167.18. The company's stock had a trading volume of 2,603,370 shares, compared to its average volume of 2,231,720. The stock has a market cap of $39.90 billion, a P/E ratio of 26.08, a PEG ratio of 1.87 and a beta of 0.66. The company has a fifty day simple moving average of $152.57 and a 200 day simple moving average of $135.64. Cardinal Health, Inc. has a twelve month low of $93.17 and a twelve month high of $168.17.

Cardinal Health (NYSE:CAH - Get Free Report) last released its earnings results on Thursday, May 1st. The company reported $2.35 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.15 by $0.20. The firm had revenue of $54.88 billion for the quarter, compared to analyst estimates of $55.33 billion. Cardinal Health had a negative return on equity of 68.84% and a net margin of 0.70%. The company's revenue was up .0% on a year-over-year basis. During the same quarter last year, the firm posted $2.08 EPS. Sell-side analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be issued a $0.5107 dividend. The ex-dividend date of this dividend is Tuesday, July 1st. This represents a $2.04 dividend on an annualized basis and a yield of 1.22%. This is a positive change from Cardinal Health's previous quarterly dividend of $0.51. Cardinal Health's dividend payout ratio (DPR) is 31.51%.

Analyst Ratings Changes

CAH has been the subject of several recent research reports. Morgan Stanley set a $181.00 price objective on Cardinal Health and gave the stock an "overweight" rating in a report on Friday, June 13th. Mizuho increased their target price on shares of Cardinal Health from $142.00 to $150.00 and gave the stock an "outperform" rating in a research report on Monday, March 31st. Evercore ISI reissued an "outperform" rating and set a $180.00 target price (up from $175.00) on shares of Cardinal Health in a research report on Thursday, June 12th. UBS Group increased their target price on shares of Cardinal Health from $150.00 to $160.00 and gave the stock a "buy" rating in a research report on Tuesday, April 29th. Finally, Citigroup reissued a "neutral" rating and issued a $170.00 price objective (up from $157.00) on shares of Cardinal Health in a research note on Friday, June 13th. Three research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $157.43.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.